• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

低α脂蛋白血症(高密度脂蛋白水平低)作为冠心病的一个危险因素。

Hypoalphalipoproteinemia (low high density lipoprotein) as a risk factor for coronary heart disease.

作者信息

Vega G L, Grundy S M

机构信息

Department of Clinical Nutrition, University of Texas, Southwestern Medical Center, Dallas 75235, USA.

出版信息

Curr Opin Lipidol. 1996 Aug;7(4):209-16. doi: 10.1097/00041433-199608000-00007.

DOI:10.1097/00041433-199608000-00007
PMID:8883496
Abstract

Low HDL levels are inversely related to risk for coronary heart disease. Several different mechanisms may account for this relationship. First, low HDL levels may be directly atherogenic; second, a low HDL often denotes high levels of other atherogenic lipoproteins (for example, remnants); and third, a low HDL frequently accompanies other coronary risk factors (for example, insulin resistance, diabetes, and raised blood pressure). This multiplicity of relationships probably explains the power of low HDL levels to predict acute coronary events.

摘要

高密度脂蛋白(HDL)水平低与冠心病风险呈负相关。几种不同的机制可能解释这种关系。首先,低HDL水平可能直接具有致动脉粥样硬化作用;其次,低HDL往往意味着其他致动脉粥样硬化脂蛋白(例如残粒)水平高;第三,低HDL常常伴有其他冠心病危险因素(例如胰岛素抵抗、糖尿病和血压升高)。这种多重关系可能解释了低HDL水平预测急性冠脉事件的能力。

相似文献

1
Hypoalphalipoproteinemia (low high density lipoprotein) as a risk factor for coronary heart disease.低α脂蛋白血症(高密度脂蛋白水平低)作为冠心病的一个危险因素。
Curr Opin Lipidol. 1996 Aug;7(4):209-16. doi: 10.1097/00041433-199608000-00007.
2
High density lipoprotein cholesteryl ester metabolism in the pony, an animal species without plasma cholesteryl ester transfer protein activity: transfer of high density lipoprotein cholesteryl esters to lower density lipoproteins and the effect of the amount of fat in the diet.矮种马(一种缺乏血浆胆固醇酯转运蛋白活性的动物)中高密度脂蛋白胆固醇酯的代谢:高密度脂蛋白胆固醇酯向低密度脂蛋白的转移以及饮食中脂肪含量的影响
Comp Biochem Physiol B Biochem Mol Biol. 2001 Sep;130(2):145-54. doi: 10.1016/s1096-4959(01)00416-x.
3
Cholesteryl ester transfer protein: friend or foe?胆固醇酯转运蛋白:益友还是劲敌?
J Clin Invest. 1996 Jun 15;97(12):2687-8. doi: 10.1172/JCI118719.
4
Metabolic and genetic control of HDL cholesterol levels.
J Intern Med. 1992 Jun;231(6):661-8. doi: 10.1111/j.1365-2796.1992.tb01255.x.
5
Lipid transfer proteins, hypertriglyceridemia, and reduced high-density lipoprotein cholesterol.脂质转运蛋白、高甘油三酯血症与高密度脂蛋白胆固醇降低
Am Heart J. 1991 Aug;122(2):601-7. doi: 10.1016/0002-8703(91)91031-h.
6
High density lipoprotein and coronary heart disease: insights from mutations leading to low high density lipoprotein.高密度脂蛋白与冠心病:源于导致低高密度脂蛋白的突变的见解
Curr Opin Lipidol. 1997 Aug;8(4):219-24. doi: 10.1097/00041433-199708000-00005.
7
Cholesteryl ester transfer activity in plasma of patients with familial high-density lipoprotein deficiency.家族性高密度脂蛋白缺乏患者血浆中的胆固醇酯转移活性。
Clin Chem. 1988 Sep;34(9):1812-5.
8
Mechanisms of HDL lowering in insulin resistant, hypertriglyceridemic states: the combined effect of HDL triglyceride enrichment and elevated hepatic lipase activity.胰岛素抵抗、高甘油三酯血症状态下高密度脂蛋白降低的机制:高密度脂蛋白甘油三酯富集与肝脂酶活性升高的联合作用
Clin Biochem. 2003 Sep;36(6):421-9. doi: 10.1016/s0009-9120(03)00078-x.
9
Pharmacological modulation of cholesteryl ester transfer protein, a new therapeutic target in atherogenic dyslipidemia.胆固醇酯转运蛋白的药理学调节,动脉粥样硬化性血脂异常的新治疗靶点。
Pharmacol Ther. 2004 Jan;101(1):17-38. doi: 10.1016/j.pharmthera.2003.10.001.
10
Absence of cholesteryl ester transfer protein-mediated cholesteryl ester mass transfer from high-density lipoprotein to low-density lipoprotein particles is a major feature of combined hyperlipidaemia.胆固醇酯转移蛋白介导的胆固醇酯从高密度脂蛋白到低密度脂蛋白颗粒的质量转移缺失是混合性高脂血症的一个主要特征。
Eur J Clin Invest. 1996 Jun;26(6):485-94. doi: 10.1046/j.1365-2362.1996.168318.x.

引用本文的文献

1
A machine learning approach to personalized predictors of dyslipidemia: a cohort study.机器学习在血脂异常个体化预测指标中的应用:一项队列研究。
Front Public Health. 2023 Sep 20;11:1213926. doi: 10.3389/fpubh.2023.1213926. eCollection 2023.
2
Age and Gender-Specific Pattern of Cardiovascular Disease Risk Factors in Saudi Arabia: A Subgroup Analysis from the Heart Health Promotion Study.沙特阿拉伯心血管疾病危险因素的年龄和性别特异性模式:心脏健康促进研究的亚组分析。
Healthcare (Basel). 2023 Jun 13;11(12):1737. doi: 10.3390/healthcare11121737.
3
Diet and Nutraceutical Supplementation in Dyslipidemic Patients: First Results of an Italian Single Center Real-World Retrospective Analysis.
血脂异常患者的饮食和营养补充剂:意大利单中心真实世界回顾性分析的初步结果。
Nutrients. 2020 Jul 10;12(7):2056. doi: 10.3390/nu12072056.
4
High Incidence of Diabetes in People with Extremely High High-Density Lipoprotein Cholesterol: Results of the Kanagawa Investigation of Total Checkup Data from the National Database-1 (KITCHEN-1).极高密度脂蛋白胆固醇人群中糖尿病的高发病率:来自国家数据库 -1 的神奈川全面体检数据调查(KITCHEN -1)结果
J Clin Med. 2019 Mar 19;8(3):381. doi: 10.3390/jcm8030381.
5
Screening Cardiovascular Risk in Patients with High Depression Scores.对抑郁评分高的患者进行心血管风险筛查。
Pak J Med Sci. 2018 May-Jun;34(3):610-615. doi: 10.12669/pjms.343.14560.
6
The association between high-density lipoproteins and estimated glomerular filtration rate in patients without severe kidney disease.无严重肾脏疾病患者中高密度脂蛋白与估算肾小球滤过率之间的关联。
Int Urol Nephrol. 2018 Jun;50(6):1105-1112. doi: 10.1007/s11255-018-1851-8. Epub 2018 Mar 28.
7
The Evidence for Saturated Fat and for Sugar Related to Coronary Heart Disease.与冠心病相关的饱和脂肪和糖的证据。
Prog Cardiovasc Dis. 2016 Mar-Apr;58(5):464-72. doi: 10.1016/j.pcad.2015.11.006. Epub 2015 Nov 14.
8
Prevalence of metabolic syndrome in turkmen ethnic groups in gorgan.戈尔甘土库曼族人群代谢综合征的患病率
J Clin Diagn Res. 2013 Sep;7(9):1849-51. doi: 10.7860/JCDR/2013/6035.3331. Epub 2013 Sep 10.
9
Znf202 affects high density lipoprotein cholesterol levels and promotes hepatosteatosis in hyperlipidemic mice.Znf202 影响高密度脂蛋白胆固醇水平,并促进高脂血症小鼠的肝脂肪变性。
PLoS One. 2013;8(2):e57492. doi: 10.1371/journal.pone.0057492. Epub 2013 Feb 28.
10
High-density lipoprotein subclass and particle size in coronary heart disease patients with or without diabetes.冠心病合并或不合并糖尿病患者的高密度脂蛋白亚类和颗粒大小。
Lipids Health Dis. 2012 May 15;11:54. doi: 10.1186/1476-511X-11-54.